Literature DB >> 18302084

Thrombophilias: when should we test and how does it help?

Nicole L Whitlatch1, Thomas L Ortel.   

Abstract

Venous thromboembolism can be a life-threatening event, occurring in ~1 in 1000 adults annually. An underlying cause for thrombosis can now be identified in up to 80% of cases, including both inherited and acquired causes of thrombophilia. In fact, it is often a combination of these risk factors that leads to the development of thrombosis. Knowing what these risk factors are for an individual patient can help with decisions regarding duration of anticoagulation, and how best to prevent a recurrent event. This article reviews both the inherited and the acquired causes of thrombophilia, focusing on the clinical scenarios in which these disorders should be suspected and on how to appropriately test for them when clinically indicated. By the conclusion of this article, the clinician should be equipped with an algorithm of how to approach a patient with a thromboembolic event, from decisions regarding which thrombophilia tests to order to how the results of these tests affect patient management.

Entities:  

Mesh:

Year:  2008        PMID: 18302084     DOI: 10.1055/s-2008-1047560

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  8 in total

1.  Futility of testing for factor V Leiden.

Authors:  Emmanuel J Favaloro; David McDonald
Journal:  Blood Transfus       Date:  2012-07       Impact factor: 3.443

Review 2.  Utility of testing for factor V Leiden.

Authors:  Massimo Franchini
Journal:  Blood Transfus       Date:  2012-07       Impact factor: 3.443

3.  Low levels of tissue factor pathway inhibitor increase the risk of cerebral venous thrombosis.

Authors:  Shaghayegh Haghjooy Javanmard; Tayebeh Shahsavarzadeh; Mohammad Saadatnia
Journal:  Adv Biomed Res       Date:  2015-01-06

4.  Personalized healthcare in clotting disorders.

Authors:  Haifeng M Wu; Lihui Xu; Daniel D Sedmak; Clay B Marsh; Mark W Wurster
Journal:  Per Med       Date:  2010-01       Impact factor: 2.512

5.  Deficiencies of proteins C, S and antithrombin and activated protein C resistance--their involvement in the occurrence of Arterial thromboses.

Authors:  Angela Mirela Soare; Constantin Popa
Journal:  J Med Life       Date:  2010 Oct-Dec

6.  High prevalence of protein C, protein S, antithrombin deficiency, and Factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident.

Authors:  Nadir Ali; Muhammad Ayyub; Saleem Ahmed Khan
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

7.  Laboratory Limitations of Excluding Hereditary Protein C Deficiency by Chromogenic Assay: Discrepancies of Phenotype and Genotype.

Authors:  Holger Seidel; Bianca Haracska; Jennifer Naumann; Philipp Westhofen; Moritz Sebastian Hass; Johannes Philipp Kruppenbacher
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

Review 8.  Genetics and the general physician: insights, applications and future challenges.

Authors:  J C Knight
Journal:  QJM       Date:  2009-09-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.